Sort
130,381 grants matching “hiv”
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$874,173Jonah B. Sacha · Oregon Health & Science University · R01 · FY2025 · AI
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$874,173Jonah B. Sacha · Oregon Health & Science University · R01 · FY2024 · AI
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$874,173Jonah B. Sacha · Oregon Health & Science University · R01 · FY2023 · AI
GH11-1151, S. AFRICA: HIV PREVENTION SERVICES, CAPACITY BUILDING ASSISTANCE AND EVALUATION ACTIVITIES F
$874,000Harry Peter Hausler · Tb Hiv Care · U2G · FY2015 · GH
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$873,988Suman Srinivasa · Massachusetts General Hospital · R01 · FY2020 · HL
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$873,986Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2011 · HL
Project 2: Limiting anti-drug antibodies
$873,853Ronald C Desrosiers · Boston Children'S Hospital · U19 · FY2024 · AI
UZ-UCSF CTU
$873,804Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2025 · AI
Mediators of fatty liver disease during HIV/SIV and cART treatment
$873,771Donald L Sodora · Seattle Children'S Hospital · R01 · FY2020 · AI
DC AIDS MALIGNANCY BANK
$873,753George Washington University · U01 · FY2001 · CA
Papillomavirus-like Particles (VLP) as Broad Spectrum Human Papillomavirus (HPV) Vaccines
$873,677Joshua Weiyuan Wang · Pathovax, Llc · R44 · FY2020 · AI
Papillomavirus-like Particles (VLP) as Broad Spectrum Human Papillomavirus (HPV) Vaccines
$873,677Joshua Weiyuan Wang · Pathovax, Llc · R44 · FY2019 · AI
Recognition Of HIV Envelope gp120 by Siglec and C-type Lectin Receptors
$873,675Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
HPV & Cervix Neoplasia in a Large, Long Term HIV + Cohort
$873,650Howard D Strickler · Albert Einstein College Of Medicine · R01 · FY2010 · CA
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication
$873,644Sumit K Chanda · Salk Institute For Biological Studies · P01 · FY2010 · AI
HIV PREVENTION TRIALS UNIT-THAILAND
$873,642Johns Hopkins University · U01 · FY2003 · AI
Safe Pregnancy by Infectious Disease Control in Kinshasa
$873,636Carl Bose · Univ Of North Carolina Chapel Hill · U01 · FY2006 · HD
Central memory CD4 T cell infection: key role in ART response and HIV persistence
$873,611Mirko Paiardini · Emory University · R01 · FY2013 · AI
Creating, evaluating, and sharing synthetic data for multinational HIV cohorts
$873,570Bryan Earl Shepherd · Vanderbilt University Medical Center · R01 · FY2025 · MH
Point Detection of Pathogens in Oral Samples via UPT
$873,450Daniel Malamud · New York University · U01 · FY2008 · DE
Develomental Core
$873,448Sarah M Fortune · Harvard University · P30 · FY2017 · AI
PS10-1001, HIV PREVENTION PROJECTS
$873,379Robert Johnston · Wyoming State Department Of Health · U62 · FY2010 · PS
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$873,331James L. Sorensen · University Of California, San Francisco · UG1 · FY2018 · DA
Basic Research Support for the CCR
$873,318Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Multilevel Influences on HIV and Substance use in a YMSM Cohort
$873,270Brian Mustanski · Northwestern University At Chicago · U01 · FY2019 · DA